Literature DB >> 16585982

Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells.

Tomoko Inoue1, Norito Katoh, Saburo Kishimoto.   

Abstract

We studied the effects of prolonged topical application of tacrolimus on immediate hypersensitivity reactions. Tacrolimus, betamethasone or petrolatum was applied to the footpad of mice for up to 28 days after immunization, and the foot-swelling response to allergen was estimated. The reactions in tacrolimus-treated mice decreased significantly from day 14, while those in betamethasone-treated mice decreased significantly from day 7. Although the number of mast cells in the foot skin of each group did not differ significantly, the percentage of degranulated mast cells decreased in the tacrolimus-treated group on days 7 and 14. The TUNEL method indicated that there were no apoptotic mast cells in the foot skin of tacrolimus-treated mice. Continuous application of topical tacrolimus ointment may suppress immediate hypersensitivity reactions by reducing the degranulation of mast cells, rather than by decreasing their number.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585982     DOI: 10.1080/00015550510011501

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis.

Authors:  Manisha S Lalan; Naresh C Laddha; Jigar Lalani; Muhammad J Imran; Rasheedunnisa Begum; Ambikanandan Misra
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

2.  A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis.

Authors:  Satoshi Takeuchi; Hidehisa Saeki; Shoji Tokunaga; Makoto Sugaya; Hanako Ohmatsu; Yuichiro Tsunemi; Hideshi Torii; Koichiro Nakamura; Tamihiro Kawakami; Yoshinao Soma; Eiichi Gyotoku; Michihiro Hide; Rikako Sasaki; Yukihiro Ohya; Makiko Kido; Masutaka Furue
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

Review 3.  Nonsteroidal Topical Immunomodulators in Allergology and Dermatology.

Authors:  Marina Jovanović; Zoran Golušin
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.